BTIG analyst Ryan Zimmerman maintained a Buy rating on Vicarious Surgical (RBOT – Research Report) today and set a price target of $7.00. The company’s shares opened today at $2.90.
According to TipRanks, Zimmerman is a 4-star analyst with an average return of 4.6% and a 40.33% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Medtronic, NuVasive, and Avita Medical.
Currently, the analyst consensus on Vicarious Surgical is a Moderate Buy with an average price target of $7.00.
See today’s best-performing stocks on TipRanks >>
Based on Vicarious Surgical’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $24.74 million. In comparison, last year the company had a GAAP net loss of $45.12 million
Based on the recent corporate insider activity of 120 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RBOT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
D8 Holdings Corp is a blank check company.
Read More on RBOT:
